My research and academic interests focus on breast cancer, particularly the identification of predictive and prognostic biomarkers, the evaluation of treatment response, and the optimization of surgical management and breast reconstruction. I am especially interested in the integration of imaging, pathology, and molecular markers to improve individualized treatment strategies, including the prediction of axillary response after primary systemic therapy. My work also encompasses endocrine therapy, chemoprevention, and translational research aimed at improving clinical decision-making and outcomes for patients with breast cancer.